Broken out by business line, first quarter net sales from Biomet’s joint constructive products totaled $393 million. Sports, extremities and trauma units reaped $127.3 million, while spine and bone healing units totaled $77.9 million. Quarterly outcomes included Biomet’s acquisition of DePuy’s trauma operations.
More Articles on Orthopedic Devices:
Smith & Nephew Launches TRIGEN Low-Profile Screw
Mazor Robotics Finalizes $15M in Financing
Implantate Extends Contracts of All Board Members
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.